Agency:
Client:
Recognising the opportunity to improve accessibility and market share, GlaxoSmithKline decided it was time to take allergy medicine Flonase over the counter, however the brand required an overhaul in order to stake a claim in the crowded allergy segment. Flonase was reinvented to create a game-changing brand. The new design eschews category conventions and signals to consumers that Flonase is anything but another ‘me-too’ antihistamine.
Agency:
Client:
Although clinically proven to work as well as its pharmaceutical competitors, pain relief brand Kytta was failing to communicate product efficacy to mainstream category buyers and to increase market share. The aim was to develop a new positioning, visual identity and communication platform to drive growth, and to attract new users whilst retaining their existing loyal consumer base.